|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.86 USD | +2.46% |
|
+6.54% | +34.97% |
| Market Cap | 7.4B 6.5B 5.99B 5.61B 10.5B 701B 10.68B 71.9B 27.83B 344B 27.77B 27.17B 1,195B | P/E 2026 * |
29.5x | P/E 2027 * | -95.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.82B 5.99B 5.52B 5.17B 9.69B 646B 9.85B 66.33B 25.67B 317B 25.62B 25.07B 1,102B | EV / Sales 2026 * |
13.4x | EV / Sales 2027 * | 42.8x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +2.36% | ||
| 1 week | +6.54% | ||
| Current month | +18.40% | ||
| 1 month | +17.90% | ||
| 3 months | +19.63% | ||
| 6 months | +32.85% | ||
| Current year | +34.97% |
| 1 week | 110.11 |  | 119.85 |
| 1 month | 92.75 | | 119.85 |
| Current year | 77 | | 119.85 |
| 1 year | 49.38 | | 119.85 |
| 3 years | 13.72 | | 119.85 |
| 5 years | 6.91 | | 119.85 |
| 10 years | 4.47 | | 119.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 2008-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 2022-04-17 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 2008-11-30 |
Harold Selick
CHM | Chairman | 71 | 2014-03-18 |
William Waddill
BRD | Director/Board Member | 69 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-09 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 05-28 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 05-11 | Fiscal year | Chief Executive Officer | 225,000 | 0.3526% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.46% | +6.54% | +120.91% | +326.95% | 7.4B | |
| +2.96% | +4.21% | -8.16% | -2.76% | 43.24B | |
| +1.36% | +7.15% | +319.01% | +557.41% | 35.25B | |
| +0.95% | +4.32% | +6.91% | +53.57% | 30.22B | |
| +2.09% | -4.22% | +10.59% | -19.83% | 28.01B | |
| -4.75% | -8.29% | +3.90% | +13.88% | 24.08B | |
| +2.49% | +0.71% | - | - | 14.16B | |
| +2.78% | +1.15% | +51.28% | +109.02% | 13.01B | |
| +2.77% | +4.02% | +9.61% | +15.31% | 12.7B | |
| +0.45% | +4.58% | +102.92% | +92.84% | 12.54B | |
| Average | +1.30% | -0.48% | +68.55% | +127.37% | 22.06B | |
| Weighted average by Cap. | +1.18% | -0.62% | +70.07% | +126.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 509M 447M 412M 386M 723M 48.24B 735M 4.95B 1.92B 23.67B 1.91B 1.87B 82.26B | 160M 140M 129M 121M 227M 15.14B 231M 1.55B 601M 7.43B 600M 587M 25.81B |
| Net income | 258M 227M 209M 196M 367M 24.46B 373M 2.51B 971M 12B 969M 948M 41.7B | -87.49M -76.86M -70.82M -66.3M -124M -8.29B -126M -850M -329M -4.07B -328M -321M -14.13B |
| Net Debt | -574M -504M -465M -435M -815M -54.37B -829M -5.58B -2.16B -26.68B -2.15B -2.11B -92.71B | -565M -496M -457M -428M -802M -53.5B -815M -5.49B -2.12B -26.25B -2.12B -2.07B -91.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-23 | US$117.88 | +2.48% | 328,115 |
| 26-06-22 | US$115.03 | +1.92% | 1,193,688 |
| 26-06-18 | US$112.86 | +1.27% | 1,533,672 |
| 26-06-17 | US$111.44 | +0.72% | 742,534 |
| 26-06-16 | US$110.64 | -1.62% | 504,794 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
